Institutional Repository of Vilnius University
Rekombinantinės žmogaus superoksido dismutazės I gryninimas ir agregacijos tyrimai /
Abstract
dc:descriptionAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, mostly linked to amyloid-like aggregation of human superoxide dismutase I (hSOD1). No effective cure for ALS has been developed for now. One of the strategies for development of therapeutics is looking for potential aggregation inhibitors in vitro. During this work 1228 mg of recombinant hSOD1 was chromatographically purified. Conditions for hSOD1 amyloid-like aggregation and aggregation kinetics were optimized. Finally, the impact of 115 compounds for aggregation kinetics and aggregate structure was tested by the use of fluorescence spectroscopy and atomic force microscopy. The results have shown that ethanol, methylene blue and EGCG act as amyloid remodelling agents and/or affects hSOD1 aggregation kinetics. 7 of 112 tested flavone derivatives are strong inhibitors of hSOD1 aggregation.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Musteikytė, Greta,
- Contributors dc:contributor
-
- Smirnovas, Vytautas
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD24072105&prefLang=en_US